Doribax



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 20.8%
Pneumonia 20.6%
Drug Use For Unknown Indication 10.4%
Sepsis 6.3%
Infection 5.2%
Peritonitis 4.9%
Pneumonia Aspiration 3.6%
Bacterial Infection 3.4%
Pyrexia 3.1%
Epilepsy 2.6%
Lower Respiratory Tract Infection 2.3%
Bipolar Disorder 2.1%
Gastrointestinal Disorder Therapy 2.1%
Hypertension 2.1%
Klebsiella Infection 2.1%
Lung Disorder 2.1%
Pain 1.8%
Acute Respiratory Distress Syndrome 1.6%
Urinary Tract Infection 1.6%
Abdominal Infection 1.3%
Convulsion 17.6%
Death 9.2%
Pneumonia 8.4%
Sepsis 6.9%
Blood Bilirubin Increased 6.1%
Renal Impairment 5.3%
Interstitial Lung Disease 4.6%
Septic Shock 4.6%
Leukoencephalopathy 3.8%
Off Label Use 3.8%
Pyrexia 3.8%
Vomiting 3.8%
Agranulocytosis 3.1%
Pancytopenia 3.1%
Renal Failure 3.1%
Thrombocytopenia 3.1%
White Blood Cell Count Increased 3.1%
Encephalopathy 2.3%
Grand Mal Convulsion 2.3%
Oxygen Saturation Decreased 2.3%
Secondary
Pneumonia 21.5%
Product Used For Unknown Indication 21.1%
Peritonitis 12.7%
Infection 5.9%
Drug Use For Unknown Indication 3.4%
Lung Abscess 3.4%
Antibiotic Prophylaxis 3.0%
Hypertension 3.0%
Sedation 3.0%
Sepsis 3.0%
Analgesia 2.5%
Dermatitis Infected 2.5%
Pyrexia 2.5%
Prophylaxis 2.1%
Thrombosis Prophylaxis 2.1%
Abdominal Infection 1.7%
Agitation 1.7%
C-reactive Protein Increased 1.7%
Cardiac Failure Congestive 1.7%
Catheter Related Complication 1.7%
Renal Impairment 14.5%
White Blood Cell Count Increased 9.1%
Fungal Sepsis 7.3%
Product Quality Issue 7.3%
Pyrexia 5.5%
Superinfection 5.5%
Acute Coronary Syndrome 3.6%
Blood Bilirubin Increased 3.6%
Blood Creatinine Increased 3.6%
Colonic Fistula 3.6%
Convulsion 3.6%
Hepatitis 3.6%
Hyponatraemia 3.6%
Leukopenia 3.6%
Liver Disorder 3.6%
Overdose 3.6%
Oxygen Saturation Decreased 3.6%
Platelet Count Decreased 3.6%
Renal Failure 3.6%
Shock 3.6%
Concomitant
Hepatitis C 19.7%
Product Used For Unknown Indication 18.3%
Acute Lymphocytic Leukaemia 11.3%
Drug Use For Unknown Indication 8.5%
Anti-infective Therapy 4.2%
Pneumonia Bacterial 4.2%
Sedation 4.2%
Anaesthesia 2.8%
Bone Marrow Transplant 2.8%
Constipation 2.8%
Contraception 2.8%
Infection 2.8%
Lymphoma 2.8%
Prophylaxis 2.8%
Pulmonary Arterial Hypertension 2.8%
Abdominal Abscess 1.4%
Analgesic Intervention Supportive Therapy 1.4%
Anticoagulant Therapy 1.4%
Aortic Valve Replacement 1.4%
Brain Abscess 1.4%
Interstitial Lung Disease 13.0%
Inappropriate Schedule Of Drug Administration 8.7%
Blood Glucose Increased 4.3%
Blood Pressure Decreased 4.3%
Chills 4.3%
Cholestasis 4.3%
Constipation 4.3%
Convulsion 4.3%
Cough 4.3%
Cyanosis 4.3%
Device Related Infection 4.3%
Haematocrit Increased 4.3%
Hypertension 4.3%
International Normalised Ratio Decreased 4.3%
Liver Disorder 4.3%
Myelodysplastic Syndrome 4.3%
Nausea 4.3%
Peripheral Coldness 4.3%
Platelet Count Decreased 4.3%
Pulmonary Embolism 4.3%